All coverage
Prysmian’s award signals ELMED has moved from paperwork to execution. The regulated disclosure shows Prysmian and the TSOs finalized the tender, with a conditional…
The latest Personal Consumption Expenditures inflation report shows that price pressures picked up slightly in August. According to the Commerce Department data released on…
Landmark SEC Case Resolution: One of the most significant developments underpinning XRP’s recent fortunes is the final resolution of Ripple’s SEC lawsuit. In early…
For the first time, Microsoft is officially putting the “Xbox” name on a handheld gaming device. In partnership with Asus’ Republic of Gamers division,…
In a dramatic escalation of his trade war, President Donald Trump on Thursday unveiled a new wave of tariffs targeting pharmaceuticals, trucks, and home…
Breeze Airways has pulled the curtain off its long-awaited international debut, unveiling a slate of new flights to popular beach destinations in Mexico and…
Pfizer’s stock has struggled in 2025, hovering near multi-year lows. At ~$23.60 per share in late September, PFE has declined about 9% since January,…
Snap’s 1.34% gain to $8.33 on Sept 25 stood out in a weak tape, with ~247M shares trading. The session left SNAP still well…
Strategic aim: Management is steering fresh equity toward debt reduction, specifically highlighting the 8.00% notes due 2027. If all base proceeds went against those…
A price‑target ceiling moved up. Craig‑Hallum raised its PLUG price target to $4, the highest on the Street, keeping a Buy stance. For a…
Price action: On Thursday, DFLI rallied 11.4% to $0.3781, swinging nearly 30% intraday on 21.66M shares — well above the recent average. Early Friday…
Datavault AI — the former WiSA Technologies that rebranded in February 2025 — secured a headline‑grabbing $150 million commitment from Scilex, delivered in Bitcoin.…
Price action: AMPY finished Sept. 25 at $5.84, trading in a wide $5.17–$6.22 intraday range and posting ~13.5M shares in volume. The step‑function move…
SciSparc’s new program aims to apply quantum algorithms to hard problems in protein folding and protein–ligand interactions, with the goal of more precise simulations…
UnitedHealthcare coverage win. On Sept. 25, Plus Therapeutics announced that UnitedHealthcare Insurance Company granted national coverage for its CNSide® CSF Tumor Cell Enumeration LDT…
Shares ripped ~50% into the close after fresh coverage amplified a Sept. 24 company release: Phase One engineering is done for TCDC, the JV…
